期刊文献+

TB-IGRA试验在调查本地健康中老年人群结核分支杆菌特异性γ-干扰素本底值的应用

Usefulness of mycobacterium tuberculosis-specific interferon-γ release assay in investigating the background value of it in healthy elderly population in the region
原文传递
导出
摘要 目的:探索本地区45岁以上健康中老年人群血浆结核分支杆菌特异性γ-干扰素本底值,为TB-IGRA定量试验广泛应用于结核病的临床诊断、疗效观察提供本底值参照依据。方法:选取100位45岁以上健康中老年人,结核分枝杆菌(MTB)γ-干扰素体外释放定量试验测定其血浆中特异性γ-干扰素含量。结果:盐城市100位健康中老年人血浆特异性γ-干扰素含量为0.1 pg/ml~7.1 pg/ml,中位数为1.1 pg/ml。结论:本地区健康中老年血浆中特异性γ干扰素含量存在一定的本底值,在使用TB-IGRA定量试验方法进行结核病临床诊断、疗效观察时要充分考虑健康人群本底值带来的影响。 Objective: To explore the background value of Mycobacterium Tuberculosis-specific Interferon-γ in healthy population with age over 45 years in Yancheng city and to provide reference for TB-IGRA test widely used in clinical diagnosis of TB and efficacy observation.Methods: Mycobacterium tuberculosis(MTB) interferon-γ test in vitro quantitative form was used to detect the specific interferon-α level in plasma of 100 selected healthy elderly over 45 years.Results: Plasma concentration of interferon-γ in 100 selected elderly was 0.1 pg/ml^7.1 pg/ml,with median of 1.1 pg/ml.Conclusion: There is a certain background value of MTB-specific interferon-γ in plasma of the elder over 45 years in the region,and the impact of which should be given full consideration when using the TB-IGRA quantitative test methods for clinical diagnosis of tuberculosis and efficacy observation.
出处 《中国卫生检验杂志》 CAS 2011年第9期2252-2253,共2页 Chinese Journal of Health Laboratory Technology
关键词 结核分支杆菌 Γ干扰素 中老年人 本底值 Mycobacterium tuberculosis Interferon-γ The elderly Background value
  • 相关文献

参考文献3

二级参考文献68

  • 1World Health Organization. Global tuberculosis control: surveillance, planning, financing. WHO report 2008, Geneva, (WHO/HTM/TB/2008.393), 2008.
  • 2National Technic Steering Group of the Epidemiological Sampling Survey for Tuberculosis(全国结核病流行病学抽样调查技术指导组).Report on fourth national epidemiological sampling survey of tuberculosis[J].中国防痨杂志,2002,25(1):3-7.
  • 3Antonucci G, Girardi E, Raviglione MC, et al. Risk factors for tuberculosis in HIV-infected persons. A prospective cohort study. The Gruppo Italiano di Studio Tubercolosi e AIDS (GISTA). JAMA,1995, 274(2):143-148.
  • 4CR Horsburgh Jr. Priorities for the treatment of latent tuberculo-sis infection in the United States. N Engl J Med, 2004, 350(20):2060-2067.
  • 5Brusasca PN, Lyashchenko KP, Colangeli R, et al. Immunological characterization of antigens encoded by the RD1 region of the Mycobacterium tuberculosis genome. Scand J Immunol, 2001, 54(5):448-452.
  • 6Harada N, Higuchi K, Yoshiyama T, et al. Comparison of the sensitivity and specificity of two whole blood interferon-gamma assays for M. tuberculosis infection. J Infect, 2008, 56(5):348-353.
  • 7Tsiouris SJ, Coetzee D, Toro PL, et al. Sensitivity analysis and potential uses of a novel gamma interferon release assay for diagnosis of tuberculosis. J Clin Microbiol , 2006, 44(8):2844-2850.
  • 8Detjen AK, Keil T, Roll S, et al. Interferon-gamma release assays improve the diagnosis of tuberculosis and nontuberculous mycobacterial disease in children in a country with a low incidence of tuberculosis. Clin Infect Dis, 2007, 45(3):322-328.
  • 9Pai M, Joshi R, Bandyopadhyay M, et al. Sensitivity of a whole-blood interferon-gamma assay among patients with pulmonary tuberculosis and variations in T-cell responses during anti-tuberculosis treatment. Infection, 2007, 35(2):98-103.
  • 10Adetifa IM, Lugos MD, Hammond A, et al. Comparison of two interferon gamma release assays in the diagnosis of Mycobacterium tuberculosis infection and disease in The Gambia. BMC Infect Dis, 2007, 7:122-130.

共引文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部